{
  "actions": [
    {
      "acted_at": "2018-05-09", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2018-05-09", 
      "action_code": "H11100", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2018-05-09", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2018-05-23", 
      "action_code": "", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5725-115", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "02"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "R000599", 
      "district": "36", 
      "name": "Ruiz, Raul", 
      "original_cosponsor": true, 
      "sponsored_at": "2018-05-09", 
      "state": "CA", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "S001156", 
      "district": "38", 
      "name": "Sanchez, Linda T.", 
      "original_cosponsor": true, 
      "sponsored_at": "2018-05-09", 
      "state": "CA", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "S000364", 
      "district": "15", 
      "name": "Shimkus, John", 
      "original_cosponsor": true, 
      "sponsored_at": "2018-05-09", 
      "state": "IL", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2018-05-09", 
  "number": "5725", 
  "official_title": "To direct the Secretary of Health and Human Services to submit to Congress a report on the extent to which Medicare Advantage plans offered under part C of the Medicare program include supplemental health care benefits designed to treat or prevent substance use disorders.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr6110-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr6-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr5776-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Benefit Evaluation of Safe Treatment Act of 2018", 
  "sponsor": {
    "bioguide_id": "R000580", 
    "district": "6", 
    "name": "Roskam, Peter J.", 
    "state": "IL", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2018-05-09", 
  "subjects": [
    "Health"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2018-05-09T04:00:00Z", 
    "text": "Benefit Evaluation of Safe Treatment Act of 2018 or the BEST Act of 2018\n\nThis bill requires the Centers for Medicare & Medicaid Services to report on the availability of supplemental health care benefits for the prevention and treatment of substance use disorders under Medicare Advantage (MA) plans, including differences between MA plans for certain individuals with special needs and other MA plans."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To direct the Secretary of Health and Human Services to submit to Congress a report on the extent to which Medicare Advantage plans offered under part C of the Medicare program include supplemental health care benefits designed to treat or prevent substance use disorders.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Benefit Evaluation of Safe Treatment Act of 2018", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Benefit Evaluation of Safe Treatment Act of 2018", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "BEST Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "BEST Act of 2018", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "BEST Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T16:23:14Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/hr/BILLSTATUS-115hr5725.xml"
}